Biofilm-Induced Bone Degradation in Osteomyelitis: Insights from a comprehensive ex vivo pathogen interaction study
- PMID: 40657461
- PMCID: PMC12255338
- DOI: 10.18295/squmj.10.2024.053
Biofilm-Induced Bone Degradation in Osteomyelitis: Insights from a comprehensive ex vivo pathogen interaction study
Abstract
Objectives: Osteomyelitis, characterised by bone inflammation due to microbial infection, presents significant healthcare challenges. While the protective role of biofilm in bacterial immunity and persistence is well-documented, its direct impact on bone degradation in osteomyelitis remains inadequately characterised. This study aimed to comprehensively examine the direct effects of biofilm-forming pathogens on human bone, providing new insights into the mechanisms of bone destruction associated with osteomyelitis.
Methods: Bone sections were collected from patients undergoing total knee replacement surgery at Sultan Qaboos University Hospital, Muscat, Oman, between January 2021 and December 2022. The samples were then inoculated with Staphylococcus aureus to simulate in vitro bone infection. Raman spectroscopy and scanning electron microscopy (SEM) were employed to analyse the bacterial interaction with bone tissue.
Results: Biofilm-forming pathogens directly contributed to bone degradation, as evidenced by SEM images showing marked trabecular destruction. Raman analysis showed a significant increase in the carbonate-to-phosphate ratio in inoculated samples (61.9%) compared to controls (47%). Additionally, mineral content decreased in inoculated samples, and the carbonate-to-amide I ratio reduced by 47% in inoculated samples and by 80% in controls. The inoculated samples exhibited an 82% shift in collagen cross-linking compared to a 72% shift in controls.
Conclusions: This research enhances the comprehension of the mechanisms underlying bone destruction in osteomyelitis and underscores the intricate role of biofilm in disease progression. These findings highlight the importance of biofilm in bone degradation and its potential implications for infection management.
Keywords: Biofilm; Bone and Bones; Infection Control; Oman; Osteomyelitis; Raman Spectroscopy; Scanning Electron Microscopy.
© The Author(s) 2025.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures



Similar articles
-
Early Bone Ischemia in Pediatric Acute Hematogenous Osteomyelitis and its Association With Progression to Chronic Osteomyelitis: New Insights From Gadolinium-enhanced Subtraction MRI.Pediatr Infect Dis J. 2025 Feb 1;44(2):102-106. doi: 10.1097/INF.0000000000004552. Epub 2024 Sep 26. Pediatr Infect Dis J. 2025. PMID: 39348495
-
Knockout of the Staphylococcus aureus virulence gene sdrC promotes Myh7 expression to inhibit the progression of osteomyelitis.J Mol Histol. 2025 Jun 5;56(3):185. doi: 10.1007/s10735-025-10447-x. J Mol Histol. 2025. PMID: 40471432
-
Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium ?Clin Orthop Relat Res. 2025 Mar 14;483(7):1225-1233. doi: 10.1097/CORR.0000000000003449. Clin Orthop Relat Res. 2025. PMID: 40106384
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Immune escape of Staphylococcus aureus mediated by osteocyte lacuna-canalicular network leads to persistent and uncured bone infection.Front Cell Infect Microbiol. 2025 Jun 2;15:1592086. doi: 10.3389/fcimb.2025.1592086. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40529302 Free PMC article. Review.
References
-
- Kavanagh N, Ryan EJ, Widaa A, Sexton G, Fennell J, O'Rourke S, et al. Staphylococcal osteomyelitis: Disease progression, treatment challenges, and future directions. Clin Microbiol Rev 2018; 31:e00084–17. https://doi.org/10.1128/CMR.00084-17. 10.1128/CMR.00084-17 - DOI - DOI - PMC - PubMed
-
- Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988; 10:103–10. https://doi.org/10.1093/clinids/10.1.103. 10.1093/clinids/10.1.103 - DOI - DOI - PubMed
-
- Al Farii H, Zhou S, Albers A. Management of osteomyelitis in sickle cell disease: Review article. J Am Acad Orthop Surg Glob Res Rev 2020; 4:e20.00002–10. https://doi.org/10.5435/JAAOSGlobal-D-20-00002. 10.5435/JAAOSGlobal-D-20-00002 - DOI - DOI - PMC - PubMed
-
- Hashmi AZA, Fazari EA, Ward MA, Masruri RA, Balushi SA, Mutani MA, et al. Predictors of developing a complex course of osteomyelitis in patients with sickle cell anaemia. Sultan Qaboos Univ Med J 2024; 24:58–62. https://doi.org/10.18295/squmj.12.2023.083. 10.18295/squmj.12.2023.083 - DOI - DOI - PMC - PubMed
-
- Junka A, Szymczyk P, Ziółkowski G, Karuga-Kuzniewska E, Smutnicka D, Bil-Lula I, et al. Bad to the bone: On in vitro and ex vivo microbial biofilm ability to directly destroy colonized bone surfaces without participation of host immunity or osteoclastogenesis. PLoS One 2017; 12:e0169565. https://doi.org/10.1371/journal.pone.0169565. 10.1371/journal.pone.0169565 - DOI - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources